Cancer cells transfer mitochondria through nanotubes to healthy neighboring cells, turning them into tumor-supporting accomplices, a new study shows.
3hon MSN
SciSparc’s subsidiary MitoCareX approved for acquisition by N2OFF shareholders; shares up 29%
SciSparc Ltd. (NASDAQ:SPRC) announced that N2OFF (NASDAQ:NITO) shareholders approved the acquisition of MitoCareX, SciSparc’s majority-owned cancer ...
Intensive cytotoxic bridging therapy is linked to delayed recovery after CAR T-cell therapy for multiple myeloma.
As many as one third of newly diagnosed multiple myeloma (MM) cases are classified as high risk, with widely varying rates of ...
This was a single-center, retrospective analysis of 42 patients with MIBC who underwent TMT at the Moffitt Cancer Center between October 2019 and April 2024 and had ≥1 post-TMT ctDNA (Signatera TM) ...
The company has developed a multiplex panel for bacterial and yeasts infections that it plans to submit for FDA clearance in 2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback